Charles Ruban
Chief Executive Officer at Verdot Ips2 SAS
Network origin in Charles Ruban first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Ruban via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| WENDEL | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| IPSEN | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal | |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | President Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Stanford University | College/University | Masters Business Admin | |
Esaote SpA
 Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Zentiva Group as
 Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Pharmaceuticals: Major | Director/Board Member | |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director of Finance/CFO Sales & Marketing | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Investment Committee Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Vassar College | College/University | Undergraduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| ESCP Europe Campus Paris | College/University | Graduate Degree Undergraduate Degree | |
| Institut National Agronomique Paris-Grignon | College/University | Graduate Degree | |
Axonics Women's Health Ltd.
 Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst | |
| DMS IMAGING | Biotechnology | Chairman | |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Director of Finance/CFO Private Equity Investor Private Equity Investor | |
| Infinity Discovery, Inc. | Director/Board Member | ||
| Stallergenes Ibérica SA | Director/Board Member | ||
Stallergenes Belgium SA
 Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Élivie SASU
 Élivie SASU Medical/Nursing ServicesHealth Services Élivie SASU provides health care services at home. Its services include respiratory assistance, infusion treatments, enteral, parenteral nutrition and insulin pump therapy. The company was founded on November 1, 1985 and is headquartered in Roubaix, France. | Medical/Nursing Services | Chief Executive Officer | |
ILTOO Pharma SAS
 ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | Miscellaneous Commercial Services | Director/Board Member | |
| Roundtable On Critical Care Policy | Director/Board Member | ||
Bank Julius Bär & Co. Ltd. /CH/
 Bank Julius Bär & Co. Ltd. /CH/ Major BanksFinance Part of Julius Bär Gruppe AG, Bank Julius Bär & Co. Ltd. is a banking company based in Zurich, Switzerland. The Swiss company provides banking services. Philipp Rickenbacher has been the CEO of the private company since 2009. | Major Banks | Director/Board Member | |
| EUROAPI | Biotechnology | Director/Board Member | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Stallergenes Italia Srl
 Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The private company has a deep understanding of allergens and is committed to innovation. | Medical Distributors | Director/Board Member Director/Board Member | |
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
| France | 24 |
| United States | 14 |
| United Kingdom | 4 |
| Italy | 4 |
| Spain | 3 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 10 |
| Finance | 8 |
| Health Services | 4 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 244 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 59 |
| Chairman | 57 |
| Chief Executive Officer | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Jean-Luc Bélingard | 40 |
| Michel de Rosen | 28 |
| Didier Hoch | 24 |
| Rafaèle Elisabeth Tordjman | 23 |
| Patrick J. Langlois | 23 |
| Jacques Theurillat | 22 |
| Maïlys Ferrère | 21 |
| Claire Giraut | 16 |
| Julie O'Neill | 16 |
| Daniel Tassé | 16 |
| Patrick Lee | 15 |
| Dirk-Jan van Ommeren | 15 |
| Don Soland | 14 |
| David Darmon | 14 |
- Stock Market
- Insiders
- Charles Ruban
- Company connections
